Stay updated on SBRT ± Nivolumab in NSCLC Clinical Trial

Sign up to get notified when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT ± Nivolumab in NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice about NIH’s website transition and its use of “Super Intelligence” alongside “Artificial Intelligence” is no longer displayed. The study record page continues to show a 403 error.
    Difference
    1%
    Check dated 2026-11-07T12:40:06.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.2 to v3.8.0; the page content otherwise remains a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T13:24:47.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the page’s 403 error message.
    Difference
    1%
    Check dated 2026-10-24T15:54:00.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The study page continues to display a 403 Forbidden error. Its footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:47:43.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The site's displayed revision identifier changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:52:12.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Revision: v3.7.0 was added to the page, and several institutional names and related terms were removed from the study details. This change alters the listed locations and collaborators shown for the trial, affecting how the study is presented to readers.
    Difference
    20%
    Check dated 2026-09-19T19:00:35.000Z thumbnail image

Stay in the know with updates to SBRT ± Nivolumab in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT ± Nivolumab in NSCLC Clinical Trial page.